The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

The Cannigma

MARCH 7, 2022

What can the current clinical trials tell us? A common theme with cannabis is that more research is needed, so thankfully there are clinical trials in the works looking at the therapeutic utility of CBN. Where can I buy CBN? Is it even legal? As long as the product contains <0.3%

THC 139

THC Sleep Clinical Trials Cannabinoids 139

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

DECEMBER 14, 2019

million in the Melbourne cannabis firm in 2018. The uptick has been represented in the patient count, as well. Although we note the early stage of the sector in Australia and the associated volatility of a nascent industry, over the same period patient numbers domestically have continued to soar,” Bell and Smith wrote in their note.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids. Using Cannabis to Quit Opioids.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

JULY 6, 2021

David Bradley, Chief Executive of South London and Maudsley NHS Foundation Trust, said, “We believe this collaboration could accelerate much-needed research that will translate into evidence-based and direct patient care for people who use our services. London, UK – 5 July 2021.

Research and Development 76

Research and Development Clinical Trials Therapy Patients 76

Puff Puff Post

OCTOBER 3, 2019

The possibility of treating the symptoms associated with autism originated when the FDA approved Epidoliolex in 2018. Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders. Epidiolex proved tremendously successful in treating epilepsy patients.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

The Joint Blog

AUGUST 27, 2020

The study found that medical cannabis use is associated with less frequent hospitalizations among patients living with sickle cell disease (SCD). It’s titled Medical marijuana certification for patients with sickle cell disease: A report of a single center experience. The study was published in the journal Blood Advances.

Patients 49

Patients Clinical Trials Data Therapy 49

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St. Bonaventure University and George Washington University School of Medicine. .

Research and Development 119

Research and Development Education Agriculture Patients 119

MedicalJane

MAY 21, 2020

A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. The Hemp Farming Act of 2018. For several hours after the mice consumed the hemp oil, they demonstrated effective pain relief.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. All other cannabis-based medicines are unlicensed.

Clinical Trials 45

Clinical Trials Data Medicine Patients 45

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. After Approval, It’s Off to Treatment Clinics.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

The Cannigma

JUNE 23, 2022

The study also found that CBGA interacts with numerous other important receptors in the body like GPR55, TRPV1 channels, as well as GABA receptors, supporting further consideration and research for use in epileptic patients. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Canna Law Blog

MARCH 4, 2020

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs.

Therapy 101

Therapy Legalization Chronic Pain DEA 101

MMJ Recs

NOVEMBER 20, 2023

These compounds may help reduce symptoms and improve the quality of life for patients. Cannabis Research and Patient Outcomes The scientific exploration of cannabinoids and their therapeutic effects has opened the door to numerous research initiatives. The outcomes of these studies have had a profound impact on patient care.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. 1 Hemp in Jordan In 2018, the Jordanian government legalized the cultivation of industrial hemp for certain purposes, such as the production of textiles and building materials.

Law 52

Law Clinical Trials Chronic Pain Recreational 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

After securing FDA approval in June of 2018, Epidiolex’s manufacturer GW Pharma announced the drug should enter the consumer market by the end of 2018. The only side effects reported from Epidiolex clinical trials were sleepiness, sedation, insomnia, fatigue, diarrhea, rash, and some infections.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Canna Care Docs

DECEMBER 11, 2018

A study published in the journal, Chemistry & Biodiversity , noted “marked improvement” in the quality of sleep in patients with chronic pain problems. [5] “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. Accessed December 5 2018. References. Hill, Kevin P.,

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. I never thought that would have been possible,” he said. However, the results were ultimately inconsistent. Gregory Rec/Staff Photographer.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

CannaMD

NOVEMBER 8, 2019

Medical Marijuana Patients Still Receive VA Benefits. While VA doctors can’t prescribe or recommend medical marijuana ( that’s what we do ), they also can’t withhold benefits because you’re a medical cannabis patient. VA clinicians may not recommend medical marijuana. PTSD Studies Support Cannabis.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

The Cannigma

MAY 6, 2021

The popularity of hemp can be traced back to the 2018 Farm Bill, a piece of legislation that effectively legalized hemp, which is defined as cannabis containing less than 0.3% The only clinical trial on delta-8-THC involving humans was done on children in Israel in 1995. Is Delta 8 THC legal? grandbrothers/123rf). delta-9-THC.

THC 145

THC Cannabinoids Concentrates Hemp 145

CannaMD

AUGUST 8, 2020

More recently, the 2018 Farm Bill expanded hemp legislation. 27, 2018, the DEA announced a rule change that placed “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 On June 25, 2018, Epidiolex became the first FDA approved cannabis-derived medication to hit U.S. In 1970, the U.S.

CBD 105

CBD DEA Research and Development Hemp 105

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD 98

CBD THC Conditions Medicine 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 29, 2019

While the market for medical cannabis is already well developed in some EU member states, only EU-wide standards can ensure patients have the same across Europe. Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said.

Medicine 45

Medicine Clinical Trials Treatment Access 45

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Medical Cannabis Seedbank

FEBRUARY 26, 2018

A regular occurrence amongst cancer patients being treated with chemotherapy is intense bouts of nausea, vomiting, and retching. So, this got the right people thinking this cannabinoid may have the same positive effect on patients whose appetite has been negatively affected by chemotherapy. When patient.

Treatment 63

Treatment Patients Clinical Trials THC 63

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora is a drug-development company founded in 2018 in Copenhagen, Denmark. Lophora – www.lophora.com.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The use of ones containing THC was legalised across the UK in November 2018. Here is the BBC report and below you will find the full press release from GW Pharmaceuticals.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

MARCH 1, 2019

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. But doctors and patients are not only facing administrative or prescribing hurdles – there’s also the cost. Legalisation.

Medicine 45

Medicine Clinical Trials Patients Treatment 45